Wuhan Wuyao Technology

Wuhan Wuyao Technology is a leading Chinese pharmaceutical company and a core subsidiary of Grand Pharmaceutical Group. Based in Wuhan, the company specializes in the research, development, and large-scale production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. It is recognized as one of the world's largest producers of adrenergic agents, including epinephrine and norepinephrine, and maintains a significant market share in cardiovascular and respiratory medications. The company's manufacturing facilities are compliant with international standards, including US FDA and EU GMP certifications, allowing it to supply critical medicines to global markets. Wuhan Wuyao Technology plays a vital role in the supply chain for emergency medicine, cardiovascular health, and ophthalmology.